{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:03:31Z","timestamp":1773792211646,"version":"3.50.1"},"reference-count":28,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mol Med"],"DOI":"10.3892\/ijmm.2018.3925","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T10:02:51Z","timestamp":1539165771000},"source":"Crossref","is-referenced-by-count":1,"title":["In\ufffdvitro analysis of microRNA-26a in chronic lymphocytic leukemia cells"],"prefix":"10.3892","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[{"name":"Blood Group Reference Laboratory, Shandong Blood Center, Jinan, Shandong 250014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang\u2011Kui","family":"Sun","sequence":"additional","affiliation":[{"name":"Blood Group Reference Laboratory, Shandong Blood Center, Jinan, Shandong 250014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"key20200713180029_b1-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.leukres.2009.01.024","article-title":"Bacterial proteins as potential drugs in the treatment of leukemia","volume":"33","author":"Kwan","year":"2009","journal-title":"Leuk Res"},{"key":"key20200713180029_b2-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pcl.2014.09.004","article-title":"Biology of childhood acute lymphoblastic leukemia","volume":"62","author":"Bhojwani","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"key20200713180029_b3-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1586\/17474086.2016.1129893","article-title":"A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia","volume":"9","author":"Randhawa","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"key20200713180029_b4-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.3109\/10428194.2015.1061193","article-title":"Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: Three new arrows aiming at the target","volume":"56","author":"Morabito","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"key20200713180029_b5-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrc.2016.8","article-title":"The molecular pathogenesis of chronic lymphocytic leukaemia","volume":"16","author":"Fabbri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"key20200713180029_b6-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"8584","DOI":"10.1038\/sj.onc.1206086","article-title":"Novel targeted therapies for Bcr-Abl positive acute leukemias: Beyond STI571","volume":"21","author":"Nimmanapalli","year":"2002","journal-title":"Oncogene"},{"key":"key20200713180029_b7-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.msec.2014.10.043","article-title":"Applications of nanoparticles in treatment and diagnosis of leukemia","volume":"47","author":"Soni","year":"2015","journal-title":"Mater Sci Eng C"},{"key":"key20200713180029_b8-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1158\/0008-5472.CAN-04-2675","article-title":"BCR\/ABL promotes dendritic cell-mediated natural killer cell activation","volume":"65","author":"Terme","year":"2005","journal-title":"Cancer Res"},{"key":"key20200713180029_b9-ijmm-42-06-3364","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1182\/blood.V94.3.853.415a12_853_863","article-title":"Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis","volume":"94","author":"Nagata","year":"1999","journal-title":"Blood"},{"key":"key20200713180029_b10-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1006\/bbrc.2001.4895","article-title":"Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax","volume":"283","author":"Jia","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713180029_b11-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1242\/jcs.03450","article-title":"MicroRNAs in human cancer: From research to therapy","volume":"120","author":"Negrini","year":"2007","journal-title":"J Cell Sci"},{"key":"key20200713180029_b12-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713180029_b13-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","article-title":"The DLEU2\/miR-15a\/161 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia","volume":"17","author":"Klein","year":"2010","journal-title":"Cancer Cell"},{"key":"key20200713180029_b14-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713180029_b15-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"N Engl J Med"},{"key":"key20200713180029_b16-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"key":"key20200713180029_b17-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jama.2010.1919","article-title":"Association of a microRNA\/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia","volume":"305","author":"Fabbri","year":"2011","journal-title":"JAMA"},{"key":"key20200713180029_b18-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jconrel.2017.04.043","article-title":"Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review","volume":"258","author":"Ramasamy","year":"2017","journal-title":"J Control Release"},{"key":"key20200713180029_b19-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1039\/C4TB01442A","article-title":"Systemic delivery of axitinib with nano-hybrid liposomal nanoparticles inhibits hypoxic tumor growth","volume":"3","author":"Choi","year":"2015","journal-title":"J Mater Chem B"},{"key":"key20200713180029_b20-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41427-018-0034-5","article-title":"Multimodal selenium nanoshell-capped Au@mSiO2 nanoplatform for NIR-responsive chemophotothermal therapy against metastatic breast cancer","volume":"10","author":"Ramasamy","year":"2018","journal-title":"NPG Asia Mater"},{"key":"key20200713180029_b21-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1016\/j.actbio.2014.08.021","article-title":"Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs","volume":"10","author":"Ramasamy","year":"2014","journal-title":"Acta Biomater"},{"key":"key20200713180029_b22-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.addr.2014.05.009","article-title":"In vivo delivery of miRNAs for cancer therapy: Challenges and strategies","volume":"81","author":"Chen","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"key20200713180029_b23-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"key20200713180029_b24-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12272-017-0995-x","article-title":"Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications","volume":"41","author":"Ruttala","year":"2018","journal-title":"Arch Pharm Res"},{"key":"key20200713180029_b25-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12551-017-0392-1","article-title":"Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer","volume":"10","author":"Ahmadzada","year":"2018","journal-title":"Biophys Rev"},{"key":"key20200713180029_b26-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.drudis.2016.10.014","article-title":"miRNA nanotherapeutics for cancer","volume":"22","author":"Ganju","year":"2017","journal-title":"Drug Discov Today"},{"key":"key20200713180029_b27-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hep.26305","article-title":"MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway","volume":"58","author":"Yang","year":"2013","journal-title":"Hepatology"},{"key":"key20200713180029_b28-ijmm-42-06-3364","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1093\/nar\/gkr1278","article-title":"MicroRNA-26a\/b and their host genes cooperate to inhibit the G1\/S transition by activating the pRb protein","volume":"40","author":"Zhu","year":"2012","journal-title":"Nucleic Acids Res"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T18:55:39Z","timestamp":1594666539000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2018.3925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":28,"URL":"https:\/\/doi.org\/10.3892\/ijmm.2018.3925","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]}}}